Stephanie Harris

1.1k total citations · 1 hit paper
17 papers, 781 citations indexed

About

Stephanie Harris is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Stephanie Harris has authored 17 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 3 papers in Emergency Medical Services. Recurrent topics in Stephanie Harris's work include Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Asthma and respiratory diseases (8 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Stephanie Harris is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Asthma and respiratory diseases (8 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Stephanie Harris collaborates with scholars based in United States, United Kingdom and Belgium. Stephanie Harris's co-authors include Eric Bradford, Ian Pavord, Bhabita Mayer, David Rubin, Frank C. Sciurba, Steven W. Yancey, Marc Decramer, Glenn Crater, Huib A.M. Kerstjens and Njira Lugogo and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Stephanie Harris

15 papers receiving 775 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

2017 384 citations Ian Pavord, Pascal Chanez et al. New England Journal of Medicine profile →

Peers

Stephanie Harris

PRM

PHYSI

EMS

SURGE

IMMUN

Helen Barnacle United Kingdom

So-Hee Lee South Korea

Tuula Toljamo Finland

Mitch Goldman United States

Claudia Stey Switzerland

F. Ioli Italy

Micah Rose United Kingdom

M. Brenner United States

Hisham Nassar Israel

Dick D. Briggs United States

Helen Barnacle United Kingdom

Stephanie Harris

556 ×0.9

PRM

465 ×0.8

PHYSI

30 ×0.3

EMS

12 ×0.3

SURGE

28 ×0.7

IMMUN

Citations per year, relative to Stephanie Harris Stephanie Harris (= 1×) peers Helen Barnacle

Countries citing papers authored by Stephanie Harris

Since Specialization

Citations

This map shows the geographic impact of Stephanie Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Harris more than expected).

Fields of papers citing papers by Stephanie Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Harris. The network helps show where Stephanie Harris may publish in the future.

Co-authorship network of co-authors of Stephanie Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Harris. A scholar is included among the top collaborators of Stephanie Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Harris. Stephanie Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pavord, Ian, Kenneth R. Chapman, Mona Bafadhel, et al.. (2021). Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO. International Journal of COPD. Volume 16. 1755–1770. 52 indexed citations

Chapman, Kenneth R., Ian Pavord, Pierluigi Paggiaro, et al.. (2018). Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function. American Journal of Respiratory and Critical Care Medicine. 197. 2 indexed citations

Sciurba, Frank C., Pascal Chanez, Jean‐Benoît Martinot, et al.. (2017). Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD. OA3194–OA3194.

Pavord, Ian, Pascal Chanez, Gerard J. Criner, et al.. (2017). Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 377(17). 1613–1629. 384 indexed citations breakdown →

Pavord, Ian, Huib A.M. Kerstjens, Stephanie Korn, et al.. (2017). Late Breaking Abstract - Dose-ranging study of mepolizumab in eosinophilic COPD. PA1366–PA1366.

Riley, John, Maggie Tabberer, Nathalie Richard, et al.. (2016). Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials. International Journal of COPD. Volume 11. 1873–1880. 6 indexed citations

Maleki-Yazdi, M. Reza, Dave Singh, Antonio Anzueto, et al.. (2015). Clinically important deterioration in patients with COPD using umeclidinium/vilanterol, tiotropium or placebo: Pooled data. PA1001–PA1001. 1 indexed citations

Decramer, Marc, Antonio Anzueto, Nathalie Richard, et al.. (2014). Effect of the once-daily long-acting bronchodilator combination umeclidinium/vilanterol (UMEC/VI) and bronchodilator monotherapy on dyspnoea as measured by the transitional dyspnoea index (TDI) in COPD. European Respiratory Journal. 44(Suppl 58). P921–P921. 2 indexed citations

Decramer, Marc, Antonio Anzueto, Edward Kerwin, et al.. (2014). Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials. The Lancet Respiratory Medicine. 2(6). 472–486. 193 indexed citations

10.

Riley, John, et al.. (2013). Use of a new dry powder inhaler to deliver umeclidinium/vilanterol in the treatment of COPD. European Respiratory Journal. 42(Suppl 57). P4145–P4145. 2 indexed citations

11.

Decramer, Marc, Antonio Anzueto, Edward Kerwin, et al.. (2013). Efficacy and safety of umeclidinium/vilanterol compared with umeclidinium or tiotropium in COPD. European Respiratory Journal. 42(Suppl 57). P3640–P3640. 1 indexed citations

12.

Decramer, Marc, François Maltais, Gregory Feldman, et al.. (2012). Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients. Respiratory Physiology & Neurobiology. 185(2). 393–399. 48 indexed citations

13.

Bateman, Eric, Gregory Feldman, Sally Kilbride, et al.. (2012). Efficacy and safety of the long‐acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD. The Clinical Respiratory Journal. 6(4). 248–257. 3 indexed citations

14.

Bateman, Eric, Gregory Feldman, Sally Kilbride, et al.. (2012). Efficacy and safety of the long-acting muscarinic antagonist, GSK233705, delivered once-daily in patients with COPD. The Clinical Respiratory Journal. no–no. 1 indexed citations

15.

Cheung, Mui, Philip A. Harris, Stanley D. Chamberlain, et al.. (2008). The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5428–5430. 36 indexed citations

16.

ZuWallack, Richard, Charles Fogarty, Michael R. McClung, et al.. (2008). EFFECT OF FLUTICASONE PROPIONATE/SALMETEROL COMBINATION ON CHANGE IN BONE MINERAL DENSITY IN SUBJECTS WITH COPD. CHEST Journal. 134(4). 104P–104P. 1 indexed citations

17.

Summar, Marshall, James V. Gainer, Mias Pretorius, et al.. (2004). Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function. Hypertension. 43(2). 186–191. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact